Lily S Cheng1, Dana M Schwartz2, Ryo Hotta2, Hannah K Graham2, Allan M Goldstein3. 1. Division of Pediatric Surgery, Department of Surgery, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114; Department of Surgery, University of California San Francisco, 500 Parnassus Ave, San Francisco, CA 94143. 2. Division of Pediatric Surgery, Department of Surgery, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. 3. Division of Pediatric Surgery, Department of Surgery, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. Electronic address: agoldstein@partners.org.
Abstract
PURPOSE: Recent evidence suggests that patients with Hirschsprung disease (HD) have abnormal neurotransmitter expression in the ganglionated proximal colon. These alterations may cause persistent bowel dysfunction even after pullthrough surgery. We sought to quantify the proportion of nitrergic neurons in the ganglionic colon of HD patients and relate these findings to functional outcome. METHODS: The proximal resection margin from 17 patients with colonic HD who underwent a pullthrough procedure and colorectal tissue from 4 age-matched controls were immunohistochemically examined to quantify the proportion of nitrergic neurons. The incidence of constipation, incontinence, and enterocolitis in HD patients was assessed retrospectively and correlated with the proportion of nitric oxide synthase (NOS) expressing neurons. Neuronal subtypes in the ganglionic colon of the Edrnb-/- mouse model of HD were also studied. RESULTS: Mice with HD had a significantly higher proportion of NOS+ neurons in ganglionic colon than normal littermates (32.0±5.6% vs. 19.8±1.2%, p<0.01). Patients with HD also had significantly more NOS+ neurons than controls (18.4±4.6% vs. 13.1±1.9%, p<0.01). Patients who experienced constipation or enterocolitis postoperatively tended toward a higher proportion of NOS+ neurons (21.4±3.9% vs. 17.1±4.1%, p=0.06). Furthermore, patients with a proportion of NOS+ neurons above the median of all HD patients (18.3%) were significantly more likely to have constipation than those below the median (75% vs. 14%, p<0.05). CONCLUSION: An overabundance of nitrergic neurons in the proximal resection margin is associated with HD and may predict bowel dysfunction following pullthrough surgery.
PURPOSE: Recent evidence suggests that patients with Hirschsprung disease (HD) have abnormal neurotransmitter expression in the ganglionated proximal colon. These alterations may cause persistent bowel dysfunction even after pullthrough surgery. We sought to quantify the proportion of nitrergic neurons in the ganglionic colon of HDpatients and relate these findings to functional outcome. METHODS: The proximal resection margin from 17 patients with colonic HD who underwent a pullthrough procedure and colorectal tissue from 4 age-matched controls were immunohistochemically examined to quantify the proportion of nitrergic neurons. The incidence of constipation, incontinence, and enterocolitis in HDpatients was assessed retrospectively and correlated with the proportion of nitric oxide synthase (NOS) expressing neurons. Neuronal subtypes in the ganglionic colon of the Edrnb-/- mouse model of HD were also studied. RESULTS:Mice with HD had a significantly higher proportion of NOS+ neurons in ganglionic colon than normal littermates (32.0±5.6% vs. 19.8±1.2%, p<0.01). Patients with HD also had significantly more NOS+ neurons than controls (18.4±4.6% vs. 13.1±1.9%, p<0.01). Patients who experienced constipation or enterocolitis postoperatively tended toward a higher proportion of NOS+ neurons (21.4±3.9% vs. 17.1±4.1%, p=0.06). Furthermore, patients with a proportion of NOS+ neurons above the median of all HDpatients (18.3%) were significantly more likely to have constipation than those below the median (75% vs. 14%, p<0.05). CONCLUSION: An overabundance of nitrergic neurons in the proximal resection margin is associated with HD and may predict bowel dysfunction following pullthrough surgery.
Authors: Rachael R Roberts; Joel C Bornstein; Annette J Bergner; Heather M Young Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-02-14 Impact factor: 4.052
Authors: I Zaitoun; C S Erickson; A J Barlow; T R Klein; A F Heneghan; J F Pierre; M L Epstein; A Gosain Journal: Neurogastroenterol Motil Date: 2013-01-29 Impact factor: 3.598
Authors: Ming Fu; Amanda J Barlow-Anacker; Korah P Kuruvilla; Gary L Bowlin; Christopher W Seidel; Paul A Trainor; Ankush Gosain Journal: FASEB J Date: 2020-06-27 Impact factor: 5.191
Authors: Jacques Gonzales; Catherine Le Berre-Scoul; Anne Dariel; Paul Bréhéret; Michel Neunlist; Hélène Boudin Journal: Sci Rep Date: 2020-09-15 Impact factor: 4.379
Authors: Andrea Nestor-Kalinoski; Kristen M Smith-Edwards; Kimberly Meerschaert; Joseph F Margiotta; Bartek Rajwa; Brian M Davis; Marthe J Howard Journal: Cell Mol Gastroenterol Hepatol Date: 2021-09-09